The Lewy Body Dementia Association (LBDA) and The Alzheimer’s Drug Discovery Foundation (ADDF) are issuing a Request for the 2012 ADDF/ LBDA Lewy body dementia Biomarker Research Award. This award will provide selected programs with up to $100,000 for one year of support to catalyze research project focused on developing innovative biomarkers that aid in early diagnosis, detection and disease monitoring of Lewy body dementia. Applications may be submitted by nonprofit academic institutions and for-profit biotechnology companies, both public and private worldwide.
Please note the following deadlines:
- Letter of Intent Submission: September 26th, 2012
- Complete Applications: October 10th, 2012
ADDF and LBDA seek to work with prospective applicants to ensure appropriate and qualified programs of interest that meet partnership objectives. An inquiry with ADDF scientific staff is therefore encouraged prior to application submission. View more information and a complete list of open funding opportunities on the ADDF website.
To further discuss scientific aspects of proposals, please contact:
Diana Shineman, Ph.D
Assistant Director for Scientific Affairs